DAS28 and DAS28-CRP parameters were used to evaluate the effectiveness of RLC- and NLC-based interventional techniques in the current study, and the results showed that both improved comparably in both RA patient groups. The gene discussed is CRP; the disease is rheumatoid arthritis.